IP Library Granted Patent US 10,159,736
Granted Patent B2
US 10,159,736 · App. 15/403,692 · Granted Dec 25, 2018

Plant virus particles for delivery of photosensitive agents

Inventor: Nicole F. Steinmetz (Cleveland, OH)
Assignee: Case Western Reserve University
A61K41/0071A61K31/555A61K45/06C12N7/00C12N2770/00023C12N2770/00032C12N2770/00042
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,159,736
App. No.
15/403,692
Granted
Dec 25, 2018
Kind
B2
Abstract

Photodynamic virus particles including a plant virus particle associated with a photosensitizing agent are described. Methods of treating cancer in a subject by administering to the subject a therapeutically effective amount of the photodynamic virus particles and illuminating a cancer-bearing region of the subject to activate the photodynamic virus particles are also described.

Claims (18)

1. A photodynamic virus particle, comprising a plant virus particle associated with a photosensitizing agent, wherein the photosensitizing agent is associated with the plant virus particle through a carboxyl dendron polymer.

2. The photodynamic virus particle of claim 1 , wherein the plant virus particle is a filamentous plant virus particle.

3. The photodynamic virus particle of claim 1 , wherein the plant virus particle is an icosahedral plant virus particle.

4. The photodynamic virus particle of claim 3 , wherein the plant virus particle is a cowpea mosaic virus particle.

5. The photodynamic virus particle of claim 1 , wherein the plant virus particle is a rod-shaped plant virus particle.

6. The photodynamic virus particle of claim 5 , wherein the plant virus particle is a tobacco mosaic virus.

7. The photodynamic virus particle of claim 1 , wherein the photosensitizing agent is a porphyrin compound.

8. The photodynamic virus particle of claim 7 , wherein the photosensitizing agent zinc ethynyl porphyrin.

9. The photodynamic virus particle of claim 1 , wherein the photosensitizing agent is associated with the plant virus particle through electrostatic interaction.

10. The photodynamic virus particle of claim 9 , wherein the photosensitizing agent is associated to the interior of the virus particle.

11. The photodynamic virus particle of claim 1 , wherein the photosensitizing agent is covalently linked to the plant virus particle.

12. The photodynamic virus particle of claim 1 , wherein at least 20 photosensitizing agent molecules are associated with the plant virus particle.

13. A method of treating cancer in a subject by administering to the subject a therapeutically effective amount of photodynamic virus particles comprising a plant virus particle associated with a photosensitizing agent, and illuminating a cancer-bearing region of the subject to activate the photodynamic virus particles, wherein the photosensitizing agent is associated with the plant virus particle through a carboxyl dendron polymer.

14. The method of claim 13 , wherein the cancer is skin cancer.

15. The method of claim 13 , wherein the cancer is melanoma.

16. The method of claim 13 , wherein the photodynamic virus particle is administered together with a pharmaceutically acceptable carrier.

17. The method of claim 13 , wherein the photosensitizing agent is zinc ethynyl porphyrin.

18. The method of claim 13 , further comprising treatment of the subject with an additional type of anticancer therapy.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jan 30, 2018
From: CASE WESTERN RESERVE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045186/0043 →
Continuity (2)
Provisional Application 62277135 · Jan 11, 2016
Related Publication 20170216438A1 · Aug 3, 2017